Document is current
Any future updates will be listed below
-
Authors
Xiao, Yuling
Chen, Jiang https://orcid.org/0000-0001-7414-8575
Zhou, Hui https://orcid.org/0000-0001-7332-4936
Zeng, Xiaodong https://orcid.org/0000-0002-1442-0538
Ruan, Zhiping
Pu, Zhangya
Jiang, Xingya
Matsui, Aya
Zhu, Lingling https://orcid.org/0000-0003-1794-3147
Amoozgar, Zohreh
Chen, Dean Shuailin
Han, Xiangfei
Duda, Dan G. https://orcid.org/0000-0001-7065-8797
Shi, Jinjun https://orcid.org/0000-0001-9200-5068
-
Funding
Funding for this research was provided by:
U.S. Department of Defense (W81XWH1910482)
- License Information
-
More Information
Article History
Received: 13 May 2021
Accepted: 13 January 2022
First Online: 9 February 2022
Competing interests
: D.G.D. received consultant fees from Bayer, BMS, Simcere, Sophia Biosciences, Innocoll and Surface Oncology and has received research grants from Bayer, Merrimack, Exelixis, Surface Oncology and BMS. No reagents or support from these companies was used for this study. No potential conflicts of interest were disclosed by other authors.
